CD274 and glioblastoma: To investigate if hematopoietic progenitors can alter glioblastoma progression and/or immunosuppression, we co-cultured bone marrow-derived HSPCs with three fluorescently labeled glioblastoma cell lines (T98G, LN229, U87) and monitored their proliferation and PD-L1 expression by flow cytometry.